Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer
Clinical trial NCT05084677 · UNKNOWN
Trial details
- NCT number
- NCT05084677
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-12-31
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.